International Journal of Endocrinology and Metabolism
Research Institute for Endocrine Sciences
Crossref
1. Symptom report and treatment experience of hypogonadal men with and without type 2 diabetes in a United States health plan
- E. F. Shortridge
- P. Polzer
- P. Donga
- R. L. Wade
2. Clinical and epidemiological characteristics of male hypogonadism in type 2 diabetes in Russia: combined analysis of study data for the period 2005–2022
- M. O. Chernova
- D. I. Esaulenko
- E. R. Rozhivanova
- R. V. Rozhivanov
- G. A. Mel’nichenko
- M. V. Shestakova
- N. G. Mokrysheva
3. Metabolic syndrome as cardiovascular risk factor in childhood cancer survivors
- V.G. Pluimakers
- M. van Waas
- S.J.C.M.M. Neggers
- M.M. van den Heuvel-Eibrink
4. The incidence and aggravating factors of male hypogonadism in type 2 diabetes
- R. V. Rozhivanov
- M. O. Chernova
- G. A. Mel’nichenko
- M. V. Shestakova
- N. G. Mokrysheva
5. Metabolic syndrome components and prostatic hyperplasia among diabetic and non-diabetic men in the Eastern DR Congo: A cross-sectional study
- L.E. Mubenga
- D. Gruson
- M.P. Hermans
- E. Bwenge
- B. Tombal
6. Serum testosterone in Nigerian men with type 2 diabetes mellitus and its relationship with insulin sensitivity and glycemic control
- Ngamariju Sepu
- Jokotade O. Adeleye
- Modupe O. Kuti